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ABSTRACT 
The involvement of adenosine 3':5'-monophosphate (cAMP) in the regulation of 
the cell cycle was studied by determining intracellular fluCtuations in cAMP levels 
in synchronized HeLa cells and by testing the  effects of experimentally altered 
levels on cell cycle traverse. Cyclic AMP levels were lowest during mitosis and 
were highest during late G-1 or early S phase. These findings were supported by 
results obtained when cells were accumulated at these  points with  Colcemid or 
high levels of thymidine. Additional fluctuations in cAMP levels were observed 
during S phase. 
Two specific effects of cAMP on cell cycle traverse were found. Elevation of 
cAMP levels in S phase or G-2 caused arrest of cells in G-2 for as long as 10 h and 
lengthened M. However, once cells reached metaphase, elevation of cAMP accel- 
erated the completion of mitosis.  Stimulation of mitosis was also observed after 
addition of CaCl~. The specificity of the effects of cAMP was verified by demon- 
strating  that:  (a)  intracellular  cAMP  was  increased  after exposure  to  methyl- 
isobutylxanthine  (MIX) before any observed effects on cycle traverse; (b) sub- 
maximal concentrations of MIX potentiated the effects of isoproterenol; and (c) 
effects of MIX and isoproterenol were mimicked by 8-Br-cAMP. 
MIX  at  high  concentrations  inhibited  G-1  traverse,  but  this  effect did  not 
appear to be mediated by cAMP.  Isoproterenol slightly stimulated G-1  traverse 
and partially prevented the MIX-induced delay. Moreover, low concentrations of 
8-Br-cAMP  (0.10-100  /~M)  stimulated  G-1  traverse,  whereas  high  concentra- 
tions (1 mM) inhibited. Both of these effects were also observed with the control, 
8-Br-5'-AMP, at  10-fold lower concentrations. 
recent years and has been the subject of several 
critical  reviews  (1,  14,  18,  40, 67).  Despite the 
research effort expended in this area, substantial 
inconsistencies  remain in the studies  reported to 
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dence supporting a regulatory role for cyclic AMP 
in cell cycle traverse. 
Although  there  is  general  agreement  that 
endogenous  adenosine  3',5'-monophosphate 
(cAMP) levels are at a  minimum during mitosis, 
changes in cAMP levels during other stages of the 
cell cycle have been determined only in a few cell 
types with  somewhat  variable results.  There  are 
also  conflicting reports  on  the  effects  of experi- 
mentally elevated cAMP levels. For example, pro- 
longation of S phase  (33,  64),  G-2 (65,  68, 71), 
and G-1 (10, 39) have been observed in response 
to  N6,2'-O-dibutyryl-cAMP (dbcAMP)  or  other 
cyclic AMP-elevating agents. On the other hand, 
cAMP  (or  dbcAMP)  has  also  been  reported  to 
stimulate  cells  in  G-1  (30,  68)  and  to  have  no 
effect  on  S  phase  (24,  68)  or  G-2  (15).  The 
interpretation  of  these  results  is  difficult,  since 
catabolites of cAMP and its analogues can exert 
potent inhibitory effects on cell growth  (43,  62), 
since other agents such as papaverine (7),  meth- 
ylxanthines (60, 66), and prostaglandins (28) may 
have effects on systems other than those involved 
with  cAMP  metabolism,  and  since  elevation  of 
cAMP in some tissues may result in the production 
of other antagonists of cAMP (25,  35). 
The  purpose  of  this  study  was  to  determine 
those  cell  cycle  loci  at  which  cAMP  might  nor- 
mally facilitate progress through the cell cycle and 
those loci at which cAMP in physiologically rele- 
vant  concentrations  might  retard  cell  cycle 
traverse.  First,  cell  cycle-dependent  changes  in 
endogenous cAMP levels were analyzed in order 
to determine when elevated or depressed  cAMP 
levels occur  during the  cell cycle.  Then, on  the 
basis of these  results,  cAMP levels were  experi- 
mentally elevated at various times either in or out 
of phase with natural cAMP fluctuations, and the 
effects  of  such  treatment  on  cell  cycle  traverse 
were analyzed. 
We adopted  a  set of criteria for demonstrating 
cAMP-specific  effects  based  on  those  originally 
outlined by  Robison et  al.  (50),  that  is:  (a)  to 
show  a  temporal  correlation  between  increased 
cAMP  levels  and  a  given  effect  on  cell  cycle 
traverse; (b) to show a  potentiation of the effect 
using a  HeLa cell adenylate cyclase agonist (iso- 
proterenol)  and a  cyclic nucleotide phosphodies- 
terase  inhibitor  (1-methyl,  3-isobutyixanthine, 
MIX);  and  (c)  to  show  that  the  effect  can  be 
mimicked  with  an  analogue  of  cAMP  (8-Br- 
cAMP). We have previously established the opti- 
mal concentrations of isoproterenol and MIX nec- 
essary for raising intracellular cAMP in HeLa cells 
(70).'  Because  of the  uncertainty in interpreting 
results obtained after prolonged exposure of cells 
to  analogues  of  cAMP  or  to  cAMP-elevating 
agents, we considered that an additional require- 
ment for specificity of an agent to affect cell cycle 
traverse relatively quickly after exposure, e.g.,  1- 
3  h.  Preliminary  reports  of  these  studies  have 
appeared previously (71, 72, 73). 
MATERIALS  AND  METHODS 
Culture Techniques 
HeLa cells, with a cell doubling time of about 24 h, 
were maintained in suspension culture at 37~  in spinner 
modified,  Eagle's minimal essential  medium  (MEM), 
supplemented with 5% calf serum, streptomycin (6,000 
~g/liter), penicillin (6,000 U/liter), (all from Grand Is- 
land Biological  Co.,  Grand Island, N.  Y.), and 0.1% 
Pluronic F-68 (Wyandotte Chemicals Corp., Wyandotte, 
Mich.). The strain of HeLa cells used in these studies was 
obtained as a gift from  Dr.  P. N.  Rao,  University of 
Colorado Medical Center, Boulder, Colo. The cells were 
routinely assayed  for mycoplasma  (4) and were free  of 
contamination. 
Synchronization Techniques 
SYNCHRONIZATION  AT  THE  BEGINNING  OF  S 
PHASE:  Cells  were  routinely  grown  to  approx. 
500,000 cells/ml, sedimented in prewarmed glassware at 
800 g  for 5 min at room temperature, and then resus- 
pended in fresh warm  Eagle's MEM (spinner formula- 
tion with 5 % calf serum) to approx. 75,000 cells/ml. The 
cells were allowed to grow for an additional 24 h before 
initiation  of  synchronization.  This  procedure  was 
adopted to provide a common culture history  and was 
found to reduce variations in basal cAMP levels. The 
cells were synchronized using a double thymidine block 
technique (5) by sequential exposure to 2 mM thymidine 
for 17 h, fresh thymidine-free media for 11 h, and 2 mM 
thymidine for an additional 13 h. The second thymidine 
block was reversed by resuspension of the cells in thymi- 
dine-free media at a density of approx. 160,000 cells/ml. 
Alternatively, the cells were synchronized by successive 
exposures to hydroxyurea (5  x  10  -4 M) for 17 h, fresh 
media for  11  h, and amethopterin (1  x  10 -6 M) plus 
adenosine (5  x  10  -5 M) for  13  h. The  amethopterin 
block was reversed by the addition of thymidine (20 p.g/ 
106 cells) (36). 
SYNCHRONIZATION  IN  MITOSIS:  In  studies  on 
' Zeilig, C. E., R. A. Johnson, E. W. Sutherland, and 
D.  L.  Friedman.  1975.  Modulation  of  intracellular 
adenosine  3':5'-monophosphate levels  in  HeLa  cells. 
Submitted for publication. 
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used in combination with a mitotic selection method (61) 
to obtain synchronized G-1 cells in relatively high yield. 
The second thymidine block was reversed by resuspen- 
sion of the cells in medium (monolayer formulation) at a 
density of 250,000 cells/ml. Aliquots of 200 ml of the 
cell suspension  were seeded into 32-oz prescription bot- 
tles and maintained in monolayer culture at 37~  After 
8  h,  the  mitotic  index  (M.I.)  of  the  population  was 
monitored  at  15-min  intervals  on  an  inverted  phase- 
contrast  microscope.  When  an  M.I.  of  15%  was  ob- 
served (usually  about  9  h  after reversal of the second 
thymidine block), the monolayer were shaken vigorously 
at  room  temperature  to  dislodge  debris,  mitotic,  and 
early G-1  cells. The monolayer medium was  decanted 
and replaced with 50 ml of prewarmed suspension  me- 
dia. The cells were incubated at 37~  until an M.I. of ca. 
20% was observed (30-60 min). These cells were then 
selectively dislodged by gentle agitation at room temper- 
ature, resuspended in prewarmed media to a density of 
about 180,000 cells/ml, and maintained in suspension  by 
magnetic  stirring at  37~  In  studies  on  the  effect of 
chemical agents on cells in M and G-l, the synchroniza- 
tion procedure was modified in that a single exposure to 
thymidine was used followed by selection of mitotic cells 
with shaking. 
Determination of Cell Cycle Parameters 
Progress through the cell cycle was monitored by cell 
density using a model FN Coulter counter (Coulter Elec- 
tronics,  Inc.,  Hialeah,  Fla.),  M.I.,  and  labeling index 
(L.I.) by autoradiography.  For L.I. measurements,  ali- 
quots of cells were exposed to [5-aH]deoxycytidine  (10.4 
Ci/mmol) or [methyl-3H]thymidine (84 Ci/mmol) (both 
from ICN Pharmaceuticals, Inc., Cleveland, Ohio) and 
processed  for  autoradiography  using  standard  proce- 
dures (44). In experiments in which the effects of chemi- 
cal agents were tested,  cells were preincubated  for  15 
min  in  fresh  media  in  order  to  remove drugs  before 
addition of [3H]thymidine  for determination of the L.I. 
L.I.  and  M.I.  were  expressed  as  percent  of the  total 
population,  and  cell density was expressed  as percent 
change from the initial seed density. 
Assay of cAMP 
For the determination of cAMP content, 15- to 30-ml 
aliquots, each containing 2 x  106 to 6  x  106 cells, were 
withdrawn from the cultures and rapidly sedimented at 
1,350  g  for  3  rain.  The  pellet  was  disrupted  by  the 
addition of 1.0 ml of 0.3  M perchloric acid containing 
5,000-10,000  cpm of [G-3H]cAMP (24 Ci/mmol, New 
England Nuclear Corp., Boston, Mass.) to monitor re- 
covery of cAMP during subsequent purification. Cyclic 
AMP was extracted from the pellet by five cycles of rapid 
freezing and  thawing  (11)  and  was purified by cation 
exchange chromatography  (Bio-Rad AG 50-X8,  100- 
200 mesh, H + form, Bio-Rad Laboratories, Richmond, 
Calif.) on 10  x  0.7 cm columns equilibrated and eluted 
with 0.1 N HCI (27). The fraction containing cAMP was 
lyophilized,  redissolved  in  0.5  ml  of  50  mM  acetate 
buffer, pH 4.0, and assayed  in duplicate essentially  ac- 
cording to the method of Gilman (27), using beef muscle 
protein  kinase  prepared  according to published  proce- 
dures (21,  34).  Values were corrected for recovery of 
[3H]cAMP  (recoveries ranged from 70-80%). 
Values  from  blank  samples,  consisting  of  0.3  M 
HCIO4 also chromatographed as described above, were 
routinely  subtracted  from  cell-derived  samples,  since 
such blanks were found to contain column-derived mate- 
rial  which  assayed  as cAMP (1.87  ---  0.26  (n  =  22) 
pmol, or 70 fmol per ml of column effluent). Otten et al. 
(38) recently made comparable observations. After cor- 
rection for blank values, the remaining assayable  mate- 
rial derived from cells could be completely abolished by 
prior incubation with beef heart cyclic nucleotide phos- 
phodiesterase.  The cAMP values derived from cell ex- 
tracts were additive with internal cAMP standards  and 
were linear with cell dilution, indicating that the samples 
did  not  contain  additional  materials  which  interfered 
with the cAMP-binding assay. Possible contamination of 
cAMP from the medium in which  the cells were grown 
was judged negligible  since no cAMP was detected in a 
20-ml aliquot of used growth medium. Cyclic AMP lev- 
els were expressed on the basis of cell protein which was 
determined  by  the  method  of  Lowry  et  al.  (29)  on 
separate  aliquots of cells  that  had  been  washed  three 
times in 0.9% NaCI to remove extracellular protein. 
Materials 
The  following compounds  were  obtained  from  the 
sources indicated: caffeine, theophylline, hypoxanthine, 
and  1-isoproterenol. HC1,  (Sigma  Chemical  Co.,  St. 
Louis,  Mo.);  N~-monobutyryl-cAMP  (mbcAMP),  5'- 
AMP Na2, 5'-GMP, 8-Br-cAMP and 8-Br-cGMP, C.F. 
Boehringer  and  Sons,  Mannheim,  Germany;  8-Br-5'- 
AMP, P-L. Biochemicals, Inc., Milwaukee, Wis. MIX 
was a gift of G. D. Searle & Co., Chicago, Ill. 
RESULTS 
Cyclic AMP Content in Synchronized 
HeLa Cells 
In  order  to  minimize the  effects of synchrony 
decay  with  time  and  to  diminish  the  chance  of 
artifact that might result from the synchronization 
method, two techniques (double thymidine block 
and  mitotic  selection)  were  used  to  achieve syn- 
chrony  during  the  earlier and  later  stages of the 
cell cycle. The results of these procedures on cell 
cycle traverse  are  illustrated  in  Figs.  1 A  and  B. 
The  rate  at which  the cell population  as a  whole 
entered  any  given  phase  of  the  cell  cycle  (the 
degree  of  synchrony)  and  the  duration  of  each 
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FIGURE  1  Synchronization  of HeLa Cells. Suspension  cultures of HeLa cells were synchronized either by 
a double thymidine block (A) or by mitotic selection (B). Progress through the cell cycle was determined 
from measurements of L.I. (percent), M.I. (percent), increase in cell density (percent), and cellular protein 
content. Closed symbols (0) represent the cumulative percentage of the total population entering a given 
phase (arrows) with time; (A---A),  M.  I., normalized to the premitotic cell density (19);  (O---0), 
ceIlular protein content normalized to the premitotic (A) or postmitotic (B) cell density.  The cumulative 
curve for S phase is a direct determination of the L. I. while the curve for G-2 was obtained from the 
maximal L.I. during S phase minus the L. I. obtained as cells exited from S phase. The cumulative mitotic 
curve was obtained by adding the percent increase in cell density to the normalized M. I. The cumulative 
G-1 curve is a direct determination of the percent increase in cell density. Values shown are the averages of 
data from five experiments for protein and  10 experiments for the other parameters. 
phase  are  given in  Table  I.  The  results  indicate 
that  the  synchrony  decays  rapidly  with  time,  a 
finding which is typical of all methods for synchro- 
nizing mammalian cells (59). The rate and time at 
which cells flowed into S phase after mitotic selec- 
tion were similar to those obtained for HeLa cells 
when other procedures  were used  (47).  With the 
double  thymidine  block  technique,  the  time  re- 
quired for 50%  of the population  to enter either 
G-2  or  mitosis  never varied  more  than  1  h  be- 
tween  experiments.  However,  with  the  mitotic 
selection technique, the time at which 50% of the 
cells entered S phase varied between 9.6 and 12.5 
h  after  selection.  The  2-4  h  discrepancy  in  the 
duration of the cell cycle in synchronized cells and 
the  population  doubling  time  in  unsynchronized 
cells (see Table I) may be a  result of unbalanced 
growth  induced  by synchronization  (16)  and  can 
be  accounted  for primarily  by  a  decrease  in  the 
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length of G-1  resulting from the thymidine block 
(Kurz,  J.  B.  and  D.  L.  Friedman,  preliminary 
observations). 
Basal cAMP levels during S, G-2, M, and early 
G-1  were  monitored  at  hourly  intervals after re- 
versal of the second thymidine block. The average 
values from seven experiments are shown  in Fig. 
2.  The  cAMP content before removal of the ex- 
cess thymidine was not significantly different from 
the 1 h value (data not shown). However, by t =  3 
h,  the  cAMP content  had  declined  to  a  level of 
about  60%  of the  1  h  value (Fig.  2).  This initial 
decline in cAMP content was prevented by readdi- 
tion  of 2  mM thymidine,  suggesting that  the  de- 
cline in cAMP levels was not a consequence of the 
resuspension procedure used to reverse the thymi- 
dine block. At t  =  4 h, an elevation of cAMP was 
observed. The magnitude of this peak was variable 
but with paired analysis was statistically significant 
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additional smaller peak was observed at t  =  6  h. 
As the cells entered G-2 (t  =  7  h), cAMP levels 
decreased  again, reaching a  minimum concentra- 
TABLE  I 
Cell Cycle Parameters in Synchronized HeLa Cells 
Rate of entry  Length of stage 
Cell cycle  Double  Mitotic  Double  Mitotic 
stage  thymidine  selection  thymidine  selection 
% cells/h  h 
S  100"  11.1  6.5  - 
G-2  34.3  -  2.1  - 
M  33.3  -  1.4  - 
G-1  18.2  32.55  -  10.2 
Generation  time (synchronized cells)  20.2 
Population doubling time (unsynchronized cells)  22-24 
* Since  the  thymidine  block  allows  cells  to  enter  S  phase  (16),  it  was 
assumed  that essentially all of the cells initiated DNA synthesis simultane- 
ously. 
~t Entrance  into G-1 after mitotic selection was not a  sigmoidal function but 
appeared  to he  exponential.  Accordingly,  the  rate  of entry  into  G-1  was 
estimated from a  logarithmic plot of the data. 
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FIGURE 2  Cyclic AMP content in cells synchronized by 
the double thymidine block method. At 0 time, the cells 
were  resuspended in fresh  thymidine-free growth me- 
dium and  allowed  to  proceed  through  the  cell  cycle. 
Thymidine (2 mM, final concentration) was immediately 
re-added to a portion of the cultures to prevent further 
DNA synthesis.  Cyclic AMP content was determined at 
various times as  indicated.  (0  O),  no thymidine; 
(&  &),  +  thymidine. Values  represent the  means 
and standard errors of three experiments with thymidine 
and seven without. Within each experiment, points rep- 
resent  average  values from  duplicate samples  from  a 
single culture, each sample  assayed for cAMP in dupli- 
cate. The data from individual  experiments were normal- 
ized  to the  1 h value (100%  =  19.0  --- 3.5 pmol/mg 
protein).  The  mean lengths of each  cell  cycle  phase 
shown  at  the  bottom  of this  and  subsequent figures 
represent values determined as described in the text. 
tion (6.97  +--  1.20 pmol/mg protein, 38  +- 5% of 
the 1 h value) at a time which corresponded to the 
mitotic peak.  As the cells completed mitosis and 
entered G-1 (t =  11-12 h), cAMP levels began to 
rise, reaching a plateau at t  =  12 h and remaining 
relatively constant until the end of the experiment 
(t  =  15 h). 
To  determine  whether  any  of  these  changes 
were  peculiar to  the  method  of synchronization, 
cells were also synchronized with hydroxyurea fol- 
lowed by amethopterin  (data  not shown).  Initia- 
tion of DNA synthesis was effected  by the  addi- 
tion of  20  /.tg of thymidine/106 cells at t  =  0  h 
without changing the growth medium. The results 
obtained in this experiment were essentially iden- 
tical to those with double thymidine block. 
To characterize more fully the timing and mag- 
nitude of the 4 and 6 h peaks (Fig. 2), an experi- 
ment was carried out in which cAMP determina- 
tions were made at 0.5 h intervals (Fig. 3). These 
results strengthen the observation that cAMP lev- 
els were elevated transiently at 4 and 6 h. In other 
experiments (Fig. 6), inclusion of a cyclic nucleo- 
tide  phosphodiesterase  inhibitor in  the  medium 
was found to potentiate greatly the magnitude of 
the 4  h  peak but not the 6  h  peak, suggesting an 
increased synthesis of cAMP at 4  h. 
The marked decline of cAMP levels during G-2 
and mitosis was investigated further to determine 
whether the minimum level was reached before or 
after the completion of cell division. Addition of 
Colcemid (0.064 p.g/ml) to synchronized cells at t 
=  7 h resulted in a decline of cAMP levels below 
that observed in the  control culture (Fig.  4).  As 
the cells accumulated in metaphase, cAMP levels 
continued to decline and at t  =  10-11  h reached a 
value of about 23% of the 1 h value. These results 
suggest that the  reaccumulation of cAMP begins 
at a point later than metaphase. 
In order to verify the results obtained using S- 
phase synchronization techniques and to examine 
alterations in cAMP levels in G-1 in greater detail, 
double thymidine-blocked HeLa cells were resyn- 
chronized by mitotic selection. At various inter- 
vals  after  collecting  mitotic  cells,  aliquots  were 
removed for cAMP determinations, the results of 
which  are  illustrated  in  Fig.  5.  After  a  lag  of 
approx.  1-2 h (as cells completed mitosis, cf. Fig. 
1), cAMP levels increased gradually to a  peak in 
late G-1 (t =  8 h) which was approximately dou- 
ble the cAMP levels in mitotic cells. As a substan- 
tial proportion of the cells entered S phase (L.I. = 
40%),  a  significant decline in cAMP content oc- 
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FIGURE 3  Cyclic AMP content measured at short intervals in cells synchronized  by the double thymidine 
block method. Cyclic AMP content was determined at 0.5 h intervals, as indicated, after reversal of the 
second thymidine block. Results represent the means and standard errors of three cell suspensions  derived 
at zero time from a common culture. 
curred (t =  10 h), followed by a second increase 2 
h  later. 
To test the possibility that the decline in cAMP 
content immediately following the G-1 peak was a 
consequence of some of the cells having entered S 
phase, 2 mM thymidine was re-added to a portion 
of the culture  at t  =  5  h  in  order to  impede the 
progression of cells into S phase (Fig. 5). Addition 
of  thymidine  completely  prevented  the  decline 
which  occurred  at  t  =  10  h  and  resulted  in  a 
continued  increase  in  cAMP  content  which  ap- 
peared  to  reach  a  plateau  between  8  and  12  h. 
These results were comparable  to those shown in 
Fig. 2  (in that when DNA synthesis is blocked by 
high  levels of thymidine,  the  S  phase  decline  in 
cAMP is not observed) and suggest that the maxi- 
mum  levels of cAMP  during  the  cell cycle  may 
occur at or near the G-1/S border. 
Effects of cAMP on Cell Cycle  Traverse 
EFFECT  OF  MIX  AND  ISOPROTERENOL  ON 
S,  G-2,  AND  M"  In  studies  on  the  effects  of 
various agents on cell cycle traverse, an autoradi- 
ographic  method  for  the  incorporation  of 
[3H]thymidine into DNA was selected for the de- 
lineation of S phase. This method was considered 
preferable  to liquid  scintillation  assays  since  it  is 
less susceptible to alterations in transport capacity 
and  precursor pool size and  since  it allows accu- 
rate determinations of the percentage of cells syn- 
thesizing DNA and the rate at which they enter or 
exit S phase. 
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Colcemid. Cell density (percent increase): (￿9  O), control; (A---A), +  Colcemid. Values represent 
the average of two experiments. 
In  preliminary  experiments,  the  incorporation 
of [aH]thymidine into DNA, as visualized autora- 
diographically, was found to be almost completely 
inhibited  by  1  mM  MIX.  In  contrast,  accumula- 
tion  of total  cellular DNA  in  synchronized  cells 
was essentially unaltered in the presence of MIX. 
This suggested that MIX was inhibiting the uptake 
of thymidine. An inhibition of thymidine transport 
has also been observed in Chinese hamster ovary 
cells in response to dbcAMP (24).  In HeLa ceils, 
we found that this inhibition was readily reversed 
within 15 min after removal of MIX. Therefore, in 
subsequent  studies,  cells were  pre-incubated  for 
15 min in drug-free medium before [aH]thymidine 
pulse labeling. Examination of autoradiograms of 
treated  and  untreated  cells showed  nearly  equal 
grain  densities,  confirming  that  this  procedure 
yielded valid estimates of the  percentage  of cells 
synthesizing DNA at any given time. 
In order to study the effects of elevated cAMP 
levels on  the  progress  of cells through  S  phase, 
cultures were exposed to 1 mM MIX immediately 
after  reversal  of  a  double  thymidine  block.  A 
single exposure  of the cells to  MIX resulted  in  a 
two- to threefold increase in cAMP levels through- 
out S phase (Fig. 6 A) except for a transient eight- 
fold increase in cAMP content 4 h after reversal of 
the  S-phase  block,  corresponding  to  the  time  at 
which  a  rise  in  basal  cAMP levels was  observed 
(cf. Fig. 2). Despite the elevation of cAMP, there 
was no demonstrable  effect of MIX either on the 
total  percentage  of pulse-labeled  cells or  on  the 
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FIGURE 5  Cyclic  AMP levels in HeLa  cells synchro- 
nized by mitotic selection. At zero time,  mitotic cells 
were selectively  dislodged from monolayer cultures pre- 
viously synchronized by a double thymidine block and 
placed in suspension culture.  Cyclic AMP,  M.I.  (not 
shown), and L.I. were monitored at various times there- 
after. At 5 h, the cultures were split and thymidine (2 
mM final concentration) was added to one group of cells. 
Cyclic AMP content: (-~  O), control; (A---A), + 
thymidine.  L.I.:  (O  O),  control.  Values  are  the 
means and standard errors of three experiments. Within 
each experiment, values for cAMP represent averages of 
duplicate samples from a single  culture. Each sample was 
assayed in duplicate. The data from individual experi- 
ments were normalized to the zero time value (100% = 
1.18 _+ 0.70 pmol/mg protein). 
rate at which they exited S phase (Fig. 6 B). How- 
ever,  a  significant prolongation of  G-2  was  ob- 
served (Fig. 6 B). The length of G-2 (as estimated 
from  the  difference  between  the  half-maximal 
points on the L.I. and M.I. curves) was increased 
from 2.3  to  10.7  h  by MIX (Fig. 6B).  Further- 
more, the rate at which the MIX-treated popula- 
tion flowed into mitosis was decreased,  and the 
time spent in mitosis appeared to be increased. 
When MIX was added to cells at  or  near the 
beginning of G-2 (6 h), a six- to eighffold rise in 
cAMP was observed (Fig. 7 A) which was associ- 
ated with a lengthening of both G-2 and mitosis 
(Fig.  7 B).  Even though cAMP levels remained 
substantially elevated, the cells were not irrevers- 
ibly blocked in G-2 and eventually progressed to 
mitosis. The effect on G-2, however, was consid- 
erably smaller than that observed after addition of 
MIX  at  the  beginning of  S  phase.  In  separate 
experiments (data not shown), the last point in the 
cell  cycle  before  mitosis that  MIX  inhibits was 
determined in unsynchronized  cells by the method 
of Petersen et al. (42). In these experiments, the 
rate  at which Colcemid-biocked metaphase cells 
accumulated began to slow 30-40 min after addi- 
tion of MIX to the culture. Addition of MIX to 
synchronized cells as late as 5 h after removal of 
thymidine was found to produce as effective a G-2 
block  as  addition  at  the  beginning of  S  phase. 
Taken together,  these  results suggest  that  MIX 
inhibits a cell cycle process which begins in late S 
phase and extends into late G-2. 
Since  methylxanthines can  exert  a  variety  of 
effects on cells perhaps unrelated to their effects 
on  cyclic  nucleotide  metabolism  (60,  66),  the 
specificity  of MIX was investigated by comparing 
its action on G-2 with that of other xanthine ana- 
logues. The agents were added at the beginning  of 
S phase to cells synchronized by a double thymi- 
dine block.  At  a  concentration of  1  raM,  only 
MIX  delayed  cells  in  G-2  significantly.  The 
lengths of G-2 were: saline, 3.0 h; theophylline, 
3.3  h; caffeine, 2.8  h; hypoxanthine, 3.2 h; and 
MIX, 10.0 h. In previous studies with logarithmic 
cells  (our  unpublished results)  j  only  MIX  pro- 
duced significant increases in cAMP content while 
other analogues had little or no effect at concen- 
trations of I  mM. 
An additional test for the involvement  of cAMP 
in the MIX-induced G-2 delay is the demonstra- 
tion that the effect of isoproterenol, an adenylate 
cyclase  agonist in these cells (70),' can be poten- 
tiated  by  a  submaximal concentration  of  MIX 
(Fig. 8). Essentially no effect of 10/~M isoproter- 
enol in the presence or absence of 0.5  mM MIX 
was observed on the  progress of cells through S 
phase. The duration of G-2 in controls was esti- 
mated  at  3.1  h,  whereas  with  isoproterenol or 
MIX alone it was 3.5 or 4.3 h, respectively. In the 
presence of both agents, the duration of G-2 was 
increased to 8.8 h. 
EFFECT  OF  CAMP  ANALOGUES  ON  THE 
DURATION  OF  S  PHASE  AND  G-2:  To  study 
the effects of cAMP analogues on the cell cycle, 8- 
Br-cAMP was chosen since it is somewhat resist- 
ant to hydrolysis by cyclic nucleotide phosphodies- 
terase and activates cAMP-dependent protein ki- 
nase (58). We have previously shown that the use 
of  native  cAMP  is  undesirable because  of  the 
cytotoxic  effects  of  5'-AMP,  which  is  readily 
formed by the action of phosphodiesterase found 
in the serum used in the growth medium.  1 N6,2 '- 
O-dibutyryl-cAMP was also found to be undesira- 
522  THE  JOURNAL  OF  CELL  BIOLOGY'  VOLUME  71,  1976 oot  
80  !  I 
6  +  Illl 
orbit  I'll  /t'o: 
o  .  .  .  /0 
HOURS  AFTER  REVERSAL OF  THYMIDINE  BLOCK 
FIGURE 6  Effect of MIX on cAMP levels during S phase and on the lengths of S phase, (3-2, and M. Cells 
were synchronized in early S phase by the double thymidine block technique. After resuspension of the 
cells  in  thymidine-free  medium,  MIX  was  added  (arrow)  to  the  indicated  cultures  to  give  a  final 
concentration of  1 mM.  (A)  Cyclic  AMP content:  (-~  O),  control; and  (A---A),  MIX.  Values 
represent the mean  -+ SE of three examples. (B) L.I.: (0  t), control; and &- -  -&), MIX Percent 
cumulative M.I.: (￿9  -  ￿9  control; and (A- -  -A), MIX. Percent increase  in cell density: (~  ~), 
control; and  (~7---V), MIX. Values shown are the average of two experiments. The cumulative M.I. 
curve is equivalent to the curve that would be obtained with a mitotic blocking agent. Each point in the 
curve is obtained by summing the M.I. (expressed as percent and corrected for increasing  cell density) and 
the percent increase in cell density. To determine the M.I., cells were fixed in media containing 2.5% 
glutaraldehyde. Concentrated samples were gently squashed with a cover slip and viewed under phase- 
contrast microscopy. Single cells without a clearly defined nucleus were scored as mitotic cells. Prophase 
cells, which could not be clearly identified by this procedure, and newly divided doublets were scored as 
nonmitotic. The M.I. is expressed as the percent of mitotic cells in the total population. 
ble for these studies,  since it is unstable  and  free 
butyrate was cytostatic (70). 
Addition  of 8-Br-cAMP  (1  mM)  at  the  begin- 
ning of S phase delayed the time at which 50% of 
the  maximum  thymidine-labeled  population  ex- 
ited S phase  by approx.  40 min, which is in con- 
trast  with the  lack of effect of isoproterenol  and 
MIX.  In  addition,  the  presence  of  8-Br-cAMP 
increased the duration  of G-2 from 3.4 to  5.9  h. 
The  magnitude  of this  effect was  comparable  to 
that  observed  with 0.5  mM MIX (Fig.  8).  How- 
ever, the interpretation of this observation is com- 
plicated by the finding that 8-Br-5'-AMP (1  mM) 
produced  similar  effects  as  8-Br-cAMP  on  tra- 
verse through both S phase and (3-2. The possibil- 
ity  that  8-Br-cAMP  was  acting  as  the  cyclic nu- 
cleotide and that these two compounds have inde- 
pendent  actions  was  supported  by  other  studies 
with  unsynchronized  cells.  2  These  experiments 
showed  that  the  inhibition  of G-2  traverse  by  8- 
Kurz, J. B. and D. L, Friedman. Manuscript in prepa- 
ration. 
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Br-cAMP, but not by 8-Br-5'-AMP, can be poten- 
tiated by MIX. 
EFFECT  OF  VARIOUS  AGENTS  ADDED 
DURING  MITOSIS  UPON  SUBSEQUENT  TRAV- 
ERSE  THROUGH  MITOSIS:  In  contrast  with 
the  premitotic  G-2  inhibitory effect  of  cAMP, 
once cells have progressed beyond the G-2 phase 
and have reached metaphase, elevated cAMP lev- 
els apparently can enhance the rate at which cells 
complete mitosis and enter G-1  (Fig.  9).  When 
synchronized cells were isolated in metaphase by 
the mitotic selection technique and exposed to  1 
mM MIX, the half-time for completion of mitosis 
was  decreased  from  approx.  48  rain to  15  min 
(Fig. 9 A). Coincident with the stimulatory effect 
of MIX, a ninefold increase in intracellular cAMP 
was ol~served  60  rain after addition of the  drug 
(Fig. 9 B). 
As illustrated in Fig.  10, a  synergistic interac- 
tion between 0.5 mM MIX and 1.0 p.M isoproter- 
enol was observed. This would further suggest that 
elevated cAMP levels may mediate the increased 
rate of exit from mitosis. 
A  variety of other agents were tested for their 
ability to mimic these  effects,  and the results of 
several experiments are summarized in Table II. 
Of the agents tested, only those capable of elevat- 
ing endogenous cAMP levels or acting like intra- 
cellular cAMP were able to stimulate cell division. 
In view of the requirement for Ca  ++ in a variety 
of cellular processes (6, 48), the effect of increas- 
ing the  Ca  ++  concentration in the  medium was 
compared with that of MIX (Fig. 11). Addition of 
2.73 mM CaCI2 to mitotic cells was found to be 
essentially as effective in stimulating cell division 
as  1  mM  MIX.  Simultaneous additions of both 
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Ca  ++ and MIX to the cultures did not result in any 
significant further  increase  in  the  rate  at  which 
mitosis was completed. 
STUDIES  ON  TRAVERSE  OF  G-I :  When 
MIX was added to synchronized cells immediately 
after mitotic selection, a concentration-dependent 
inhibition of the  flow  of cells  into S  phase  was 
observed (Fig.  12 A). The effect of  1 mM MIX 
was  associated  with  a  relatively large  initial in- 
crease in cAMP content for the first 4 h of expo- 
sure to MIX (Fig. 12 B). At later times, however, 
cAMP  content decreased  despite  the  continued 
presence of MIX. Theophylline, caffeine, and hy- 
poxanthine (at concentrations of I  mM) were all 
found to extend only slightly (<1 h) the length of 
G-1. 
In order to ascertain whether or not the inhibi- 
tory effects of MIX could be attributed to a mech- 
anism involving cAMP, cultures were  treated  at 
various times after mitotic selection with  10  /zM 
isoproterenol with or without 0.5 mM MIX (Figs. 
13 A, B, and C). The inhibitory effect of 0.5 mM 
MIX appeared to be maximal when added early in 
G-l, shortly after most of the ceils had completed 
cell division (Fig.  13 B). Addition of MIX either 
before or after this time produced a less effective 
G-1  delay.  Isoproterenol  by  itself had  a  slight 
stimulatory effect on entrance into S phase,  but 
unexpectedly partially reversed  the  MIX  inhibi- 
tion of DNA synthesis (Fig. 13A, B, and C). 
These results prompted further experiments on 
the effect of isoproterenol by itself. It was found 
that exposure of cultures to 10/zM isoproterenol 
either at zero time or at 3 h shortened the length 
of G-1 by 0.5 h (P <  0.01) and 1.1 h (P <  0.02), 
respectively (not shown). However, with a range 
of concentrations of MIX from 2 to 200 /~M and 
isoproterenol from 0.1 to l0/zM, it was not possi- 
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F[C;URE 9  Effects of MIX on cyclic AMP levels and on 
completion of mitosis.  MIX was added to synchronized 
cells, immediately after isolation in metaphase by mitotic 
selection, to give a  final  concentration of  1 raM.  (A) 
Effect  of  MIX  on  completion  of  mitosis.  M.I.: 
(-~  0),  control;  and  (A---A),  +  MIX.  Percent 
increase  in cell density: (￿9  control; and (A)  +  MIX. 
Values  represent  the  mean  z  SE  from  four separate 
experiments. Mitotic cells were determined as described 
in  the legend of Fig. 6.  (B) Effect of MIX on cAMP 
content of mitotic cells, cAMP levels were measured 60 
rain  after the addition of either 0.9%  saline  or  1 mM 
MIX  in  0.9%  saline.  Solid bar,  control;  broken  bar, 
MIX. Vertical lines represent the range of cAMP levels 
in duplicate experiments. 
ble to demonstrate  a  synergism  between subopti- 
mal doses of these two agents. These results sug- 
gested that either isoproterenol or MIX was acting 
by a  mechanism which did not involve cAMP. 
In an attempt to distinguish among these possi- 
bilities, the effect of 8-Br-cAMP on the length of 
(3-1  was  examined.  8-Br-cAMP  (1  mM)  was 
added for various intervals of time to synchronized 
cells (Fig. 14 A, B, and C). The effects of 8-Br-5'- 
AMP were also examined in these experiments to 
control for the possible hydrolysis of 8-Br-cAMP 
by  serum  phosphodiesteraseJ  Continuous  expo- 
sure  of the  cells to  8-Br-cAMP over the  interval 
from  0  to  12  h  delayed  the  flow of cells into  S 
phase by about 1 h. However, a greater inhibition 
was  observed  in  response  to  8-Br-5'-AMP  (Fig. 
14A).  The  effect  of  8-Br-cAMP  was  not  seen 
when it was added at a  later time (Fig.  14B)  nor 
when  the cells were  first  treated  and  then  resus- 
pended  in drug-free medium  (Fig.  14C).  On  the 
other hand, 8-Br-5'-AMP produced significant in- 
hibition  when  added  at  3  h  (Fig.  14B),  and  the 
effects were not completely reversed upon  its re- 
moval (Fig.  14 C). 
The  results  shown  in  Fig.  15  suggest  an  addi- 
tional effect of 8-Br-cAMP which may be due to 
its hydrolysis to 8-Br-5'-AMP. Varying concentra- 
tions of 8-Br-5'-AMP or 8-Br-cAMP were added 
to  synchronized  cultures  3  h  after  mitotic  selec- 
tion,  and  the  L.I.  was  measured  at  10  h  (Fig. 
15A).  In  contrast  to  the  inhibitory  effects  ob- 
served with high concentrations, at low concentra- 
tions (10-s-10 -7 M) both nucleotides produced  a 
50% stimulation in the labeling indices (indicative 
of  a  shortening  of  G-l).  8-Br-5'-AMP  was  ap- 
proximately one order of magnitude  more potent 
than  8-Br-cAMP.  The  estimated  half-maximal 
concentrations  for  the  rising  phase  of  the  dose 
response  curves were approx.  6  nM  for  8-Br-5'- 
AMP and  40 nM for 8-Br-cAMP. At concentra- 
tions greater  than  10 -4 M,  8-Br-5'-AMP  was  in- 
hibitory. In contrast,  8-Br-cAMP was stimulatory 
at all concentrations tested,  but the magnitude of 
this stimulation decreased at concentrations in ex- 
cess of  10 -4 M.  Both the inhibitory  and  st[mula- 
tory  effects of  8-Br-cAMP  may  be  attributed  to 
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FIGURE 10  Effect of isoproterenol and MIX on mito- 
sis. Agents were added at zero time and  M.I. was fol- 
lowed for 60 rain.  (-"  t),  0.9% saline; (￿9169 
isoproterenol  (1  p.M);  (V---~7),  MIX  0.5  raM;  and 
(I'---Y),  isoproterenol  +  MIX. Values represent the 
mean -+ SE from three experiments. 
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Effect of Various Agents on Completion  of Cell 
Division 
Addition  Concentration  M.I. 
Saline 
MIX 
Isoproterenol 
Isoproterenol  +  MIX 
Carbaehol 
Carbachol  +  MIX 
MIX 
Theophylline 
Caffeine 
Hypoxanthine 
8-Br-cAMP 
mheAMP 
8-Br-5'-AMP 
5'-AMP 
8-Br-cGMP 
5'-GMP 
0.9% 
0.2 mM 
1  ~M 
10  #M 
1  mM 
% of control 
100  (15) 
75 --- 4"  (4) 
88 •  6  (4) 
53 •  7"  (4) 
94 •  5  (4) 
85 •  5  (4) 
4o •  1"  (7) 
100  (2) 
102  (2) 
99 •  2  (3) 
64 •  1'  (4) 
68 -+ 5' (4) 
102 •  9  (4) 
97 -+ 5  (4) 
106 • 8  (4) 
98 Z 5  (4) 
HeLa cells were synchronized by mitotic selection, and incubated for 45 rain 
in the presence of various agents at the indicated final concentrations. The 
initial control M.I. was 62 +  4%. Of the remaining cells, 27 •  4% were 
postmitotic doublets. The results of several experiments are expressed as a 
percent  of the  control  at  45  min  (30  x  4%).  Numbers  in  parentheses 
represent the number of observations. 
* P  <  0.01 compared  with control saline. 
the  presumed  formation  of  8-Br-5'-AMP or  its 
catabolites. 
DISCUSSION 
The absolute changes in cAMP at any given time 
must be viewed as an approximation, since they 
will be greatly affected by the degree  of cell syn- 
chrony at that time. In general, if there is a sharp 
rise  (or fall) in cAMP at a  particular time in the 
cell cycle, the measured change would always rep- 
resent an underestimate of the  true  value for an 
individual cell. Thus, when cells were accumulated 
either  in mitosis with  Colcemid or  at  the  G-1/S 
border with 2 mM thymidine, the mean change in 
the cAMP content of the whole population would 
be increased as the individual cells in the popula- 
tion reached a uniform position in the cell cycle. If 
the duration of a cAMP fluctuation is brief enough 
(ca.  5-15  min),  it  is  likely  that  such  a  change 
would escape detection entirely. 
In spite of these limitations, the results reflect 
certain  broad  cell  cycle  changes  which  may  be 
summarized  as  follows:  (a)  Cyclic  AMP  levels 
begin to rise early in G-1  and reach a  plateau in 
late G-1. (b) Coincident with the G-1  to S transi- 
tion or shortly thereafter,  cAMP levels begin to 
decline; this decline continues for approx. 50% of 
the total length of S-phase.  (c) During the latter 
half  of  S-phase,  at  least  one  and  possibly  two 
transient elevations in cAMP content occurs.  (d) 
As cells traverse G-2 and M, the concentration of 
cAMP declines, attaining its lowest level in mito- 
sis. 
Some general aspects of the changes in cAMP 
content observed in this study with malignant cells 
have  also  been  observed  in  untransformed cells 
(52,  53,  54,  56).  However,  the  levels of cAMP 
during the first half of G-2 appear to be somewhat 
variable among different cell lines. In HeLa cells 
under  the  culture  conditions employed  in  these 
studies  and  in  some  other  cell  types  (10,  54), 
cAMP levels appear  to  decline throughout  G-2. 
On  the  other  hand,  in  human  lymphoid  (33), 
mouse lymphoma (Zeiling C. E., R. A. Johnson, 
and  D.  L.  Friedman,  unpublished observations) 
and  rat  Novikoff hepatoma  cells  (22),  a  rise  of 
cAMP content in late S  and early G-2 has been 
observed. Several reports confirm that cAMP lev- 
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Effect  of  calcium  and  MIX  on  mitosis. 
CaCl2 or MIX was added to mitotic ceils at zero time in 
final concentrations  of 2.73 mM and 1 mM, respectively. 
(t~----@), control; (A---A), MIX; (O---O), CaCl2; 
and  (D---D),  CaC12  +  MIX.  Values represent  the 
mean -+ SE from triplicate  cell suspensions. 
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during mitosis (10, 32, 33, 53, 54, 56). The recent 
observation  that  cAMP  levels vary  cyclically in 
cleaving sea urchin zygotes, exhibiting minima at 
each cytokinesis (69), suggests that this phenome- 
non may be a common feature of mitosis in eucary- 
otic animal cells. 
A  number of reports confirm a  peak in cAMP 
levels during G-1 phase. Reinitiation of growth in 
quiescent fibroblasts by fresh serum (10,  19, 38, 
51, 53), trypsin (10, 38), or viral infection (49) is 
associated with  a  transient  fall in  cAMP.  How- 
ever, cAMP content eventually returns to a rela- 
tively high level before initiation of DNA synthesis 
(10,  53).  Prereplicative peaks in  cAMP content 
have also been observed in regenerating liver (31, 
57, 63) and in synchronized cultures of CHO cells 
(52, 56) and human lymphoid cells (32, 33). The 
timing of these peaks in relation to DNA synthesis 
is quite variable in the different systems, suggest- 
ing that increased cAMP levels are not the imme- 
diate  signal for  initiation of S  phase.  However, 
cAMP may be  intimately involved in  the  events 
leading up to DNA synthesis. 
Several lines of evidence support  a  significant 
role for the prereplicative rise in cAMP (3, 12, 23, 
30, 41,52, 57, 68). However, in studies with $49 
lymphoma cells, Coffino et al. showed that genetic 
mutants deficient in cAMP-dependent protein ki- 
nase progressed through an essentially normal cell 
cycle  (15).  This  was  interpreted  as  indicating a 
lack of involvement of cAMP in the regulation of 
the cell cycle. However, such an interpretation is 
premature  until  it can  be  shown  that:  (a)  other 
cellular compensatory mechanisms do not operate 
to bypass a defective regulatory subunit of cAMP- 
dependent  protein  kinases,  (b)  mutant  kinases 
(26)  as measured  in  vitro are  totally inactive in 
vivo, and (c) receptor proteins other than protein 
kinase are not involved in cAMP effects on the cell 
cycle. 
An  inverse correlation has  been  reported  be- 
tween growth rate and cAMP content (37).  Our 
results  suggest  a  plausible explanation  for  these 
observations.  Since  growth  rate  is  primarily  a 
function of the length of G-1 (45), the more rapid 
the growth rate the greater will be the proportion 
of  cells  in  S,  G-2,  and  M  in  an  asynchronous 
culture. This would predict an inverse relationship 
of cAMP levels with growth rate, assuming that 
relatively high cAMP levels are maintained during 
most of G-1 and lower levels at other stages of the 
cell cycle. 
Several reports indicate  that  cAMP levels are 
lower  in  malignant  cells  when  compared  with 
those  of untransformed  cells during  exponential 
growth  (13,  37,  55).  It would be  of interest  to 
know  whether this difference is reflected in only 
one part of the cell cycle or whether cAMP levels 
are  proportionately  lower  in  all  stages.  Direct 
comparison within the  same cell line before and 
after transformation will be required to establish 
such differences. 
In  the  studies of cell cycle  traverse,  we  have 
attempted to determine the effects of cAMP levels 
elevated experimentally in phase or out of phase 
with naturally occurring cell cycle-dependent fluc- 
tuations in  endogenous  cAMP.  Where  possible, 
we  have  studied  effects  demonstrable  within  a 
relatively short period after cellular cAMP levels 
were elevated because of the uncertainty in judg- 
ing  physiological specificity of  long-term  treat- 
ments.  Elevation  of intracellular cAMP  in  cells 
which  have  initiated DNA  synthesis  and  which 
normally  exhibit  falling  cAMP  levels  (early  S 
phase)  had little or no  effect on  the  subsequent 
timing of S  phase.  Our results are in  agreement 
with  those of Willingham et al. in  normal fibro- 
blasts  (68)  but  are  in  contrast  with  studies  on 
human lymphoid cells (33) and rat hepatoma cells 
(64). These discrepancies may reflect differences 
in  cell lines or  nonspecific effects  of the  agents 
used to elevate cAMP. 
Our studies indicate that  high levels of cAMP 
inhibit cell cycle traverse in G-2. A role for cAMP 
is supported by several observations. First, MIX 
raises  cAMP  and  inhibits  progression  of  cells 
through  G-2. Other methylxanthines which have 
little effect on cAMP levels in these cells  1 did not 
affect passage through G-2. Secondly, the combi- 
nation of isoproterenol, which activates adenylate 
cyclase in these cells (70), 5 and  suboptimal con- 
centrations of MIX  leads to  a  markedly poten- 
tiated inhibition of O-2 traverse. The inhibition of 
G-2  traverse by high cAMP levels together with 
the demonstration that endogenous cAMP levels 
normally fall during G-2 indicates the existence of 
a  cAMP-mediated  G-2  control  point  in  HeLa 
cells.  The  mechanism  for  the  inhibition  of G-2 
traverse by cAMP is not known, but our observa- 
tion of a more complete G-2 block with the addi- 
tion of MIX before onset of G-2 suggests an addi- 
tional level of complexity in the mechanism of this 
effect of MIX. Whatever the mechanisms underly- 
ing the  effect of cAMP in  G-2. the  endogenous 
level of cAMP during late S phase and G-2 could 
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such regulation occurs naturally is supported by 
the findings that, in a number of tissues, catechol- 
amines or dbcAMP have been shown to slow G-2 
traverse (8, 46, 65, 68), that in certain tissues a 
significant proportion of cells are arrested in G-2 
in vivo (20),  and that,  in vitro, passage  of cells 
through G-2 is serum dependent (2). 
In contrast with the inhibitory effect of premi- 
totic elevations of cAMP on G-2 and M, increased 
cAMP levels during mitosis were found to stimu- 
late the completion of cell division as evidenced by 
the rapid fall in M.I. (Figs. 9,  10, and 11). The 
possibility has  been  considered  that  this  effect 
resulted from an inhibition of G-2 cells contami- 
nating the mitotic population rather than from a 
stimulation of mitosis. This possibility was ruled 
out by the finding that the cell number increased 
more rapidly in MIX-treated mitotic cells than in 
control cells. Furthermore, in many recent experi- 
ments the initial M.I. was as high as 95%. Even if 
the remaining 5 % of the cells were all in G-2, their 
inhibition could account for only a small fraction 
of  the  mitotic  effect  observed  after  MIX?  Al- 
though cAMP levels were not measured, a some- 
what  similar effect  of epinephrine on  mitosis in 
mouse epidermis has been reported (9,  17). 
If cAMP is normally involved in events leading 
to  completion of  mitosis,  a  rise  in  intracellular 
cAMP levels in late M  would be expected. With 
the  synchronization methods  employed  here,  a 
highly  transient increase  in  cAMP  at  this  time 
would  not  be  easily  detected.  Using  a  slightly 
different approach  to this problem, we  have re- 
cently found a transient increase in the production 
of cAMP at a time which does correlate with the 
latter half of mitosis  4 in Novikoff hepatoma cells. 
The ability of increased extraceilular calcium lev- 
els to mimic the cAMP-induced stimulation of cell 
division suggests  a  possible  mechanism for  the 
effect of cAMP.  Cyclic AMP could promote  an 
increased concentration of free  cytoplasmic cal- 
cium either by promoting cellular uptake of cal- 
cium from the medium or by releasing sequestered 
intracellular stores of calcium. 
Interpretation of the effects of various agents on 
G-1  in these  studies is obviously complex. Since 
isoproterenol failed to enhance the inhibitory ef- 
a Kumar, K. and D. L. Friedman. Manuscript in prepa- 
ration. 
4 Zeilig, C. E. and N. D. Goldberg. Manuscript in prep- 
aration. 
fects of MIX, the ability of high levels of MIX to 
prolong G-1  may not be due to its inhibition of 
cAMP  phosphodiesterase.  For  example,  MIX 
could elevate  cellular cGMP  levels,  alter  trans- 
membrane ion fluxes, etc.  The  results obtained 
with cyclic nucleotide analogues support the con- 
clusion  that  cAMP  is  ineffective  as  a  negative 
modulator of G-1 traverse in HeLa cells. Since 8- 
Br-5'-AMP  was  far  more  effective  than  8-Br- 
cAMP and since it is known that both compounds 
are  at  least  partially metabolized (58),  it  seems 
likely that the effects of the cyclic nucleotide could 
be attributed to 8-Br-5'-AMP or its metabolities, 
e.g., adenosine. Independent actions of these two 
agents cannot be excluded. The observations that 
isoproterenol is slightly stimulatory in G-1, that it 
can partially prevent the MIX-induced inhibition, 
and that cAMP levels are naturally elevated dur- 
ing this stage suggest a permissive role of cAMP in 
G-1 traverse. Although our data are not inconsist- 
ent  with  this  hypothesis,  more  substantial  evi- 
dence is required to verify such a role. 
In conclusion, our studies and those  in other 
laboratories implicate a role of cAMP in the regu- 
lation of the cell division cycle. However, none of 
the possible underlying  mechanisms have yet been 
established by which it might influence a given cell 
cycle event. The ability to establish such roles and 
to  evaluate  causal  mechanisms  is  severely  im- 
paired by our lack of understanding of the funda- 
mental processes  that  occur  in  the  cell  division 
cycle. In addition, the  mechanisms that underlie 
fluctuations in cyclic  nucleotides during the  cell 
cycle  are  also not established, and further work 
will be required to ascertain whether the appropri- 
ate  cyclases  or diesterases are involved. Perhaps 
then,  more  important questions could be  posed 
regarding the mechanisms by which the activities 
of those enzymes may be regulated. 
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